Kirsten Gormly

Kirsten Gormly

Adelaide Medical School

Faculty of Health and Medical Sciences


Clinical radiologist with subspecilaty expertise in oncology and pelvic imaging. Clinical Senior Lecturer - The University of Adelaide, Past chair & current executive member - Abdominal Radiology Group of Australia & New Zealand, Corresponding Fellow - European Society of Gastrointestinal and Abdominal Radiology, Fellow - International Cancer Imaging Society, Member - Society of Abdomial Radiology (USA) Anorectal Disease Focused Panel.
Research interests include rectal MRI, prostate cancer, Dual energy CT, improvements in radiology education and reporting, with national and international colaborations.
Educational contributions predominantly involve national and international radiologist and non radiology meetings and workshops. Contributions to face to face teaching at The University of Adelaide in MS1 & MS4 and virtual lectures for MS3.

My primary research is focused on gastrointestinal and urological conditions, in particular rectal and prostate cancer.  I am involved in imaging based research as well as collaborations which assess imaging as part of disease assessment and management.  

I also focus on assessing the uptake and use of guidelines for technical quality and reporting in oncological imaging.  Poor image quality reduces the ability to report accurately and failure to use standardised guidelines impedes the ability to compare international research findings accurately. 

Assessing new imaging technologies in oncological and abdominal imaging, such as Dual energy CT, Photon counting CT, high gradient MRI systems and AI assisted MRI sequences is an additional area of research activity. 

 

SPAR:  A randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer’. M Jameson, S Ackland, M Pearse , S Ngan, F Frizelle, A Stevenson, K Gormly. M Arendse. 2018

  • Health Research Council on NZ (HRC) $NZ 1,399,053
  • Cancer Society New Zealand $NZ 149,290,

RENO: Prospective Study of ‘Watch and Wait’ Strategy in patients with Rectal Cancer who have developed a Clinical Complete Response with concurrent Chemo-radiotherapy.  C Karapetis, D Wattchow, S Vatandoust, L Sposato.  CI. 2018

  • AGITG innovation grant $200,000

 Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests. E Symonds, GP Young, M Michael, ..... A Roy,  C Karapetis, K Gormly. 2020

  • AGITG innovation grant $200,000

PETACC 6 Trial: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. TJ Price, J Harvey, N Tebbutt, J Zalcberg, J Simes, G Hruby

  • 2013. Cancer Australia + Cancer Council NSW 123,331 + 19,624.  
  • 2009-11. Cancer Australia 477,800

Contributions to the new  BMS / MD Medical Course include;

MS1 & 2 imaging content

MS3 lectures:

  • Imaging in Prostate cancer
  • Imaging in Testicular cancer
  • Imaging in Ovarian Cancer
  • Imaging in Uterine cancer
  • Imaging in Cervix cancer

Planned 4th year MD - face to face session; General Surgical Imaging

Extensive vocational lecturing to radiologists and other medical and allied health groups in national and international forums, including conferences and workshops.


Connect With Me
External Profiles